Stay updated on Pembrolizumab/Gemcitabine in ABC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab/Gemcitabine in ABC Clinical Trial page.

Latest updates to the Pembrolizumab/Gemcitabine in ABC Clinical Trial page
- Check5 days agoChange DetectedThe page revision updated from v3.6.4 to v3.6.5, indicating a new internal version for the page with no visible content changes.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page now displays a new site revision, v3.6.4, replacing the previous v3.6.3, indicating a release update to the ClinicalTrials.gov interface. This change appears to be a behind-the-scenes version update and does not modify the study data or layout.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedThe page now displays Revision: v3.6.3, replacing Revision: v3.6.2. This indicates an updated version of the study documentation referenced on the page.SummaryDifference0.0%

- Check48 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2, representing a software version update rather than a content change.SummaryDifference0.0%

- Check62 days agoChange DetectedRecruitment is now closed on the study page, indicated by the note 'No longer looking for participants.' The update also adds new help and navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment label.SummaryDifference0.4%

- Check69 days agoChange DetectedRevision tag updated from v3.5.4 to v3.5.5, indicating a page version update.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab/Gemcitabine in ABC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab/Gemcitabine in ABC Clinical Trial page.